What is the purpose of this trial?
Evaluation of the Efficacy and Safety of Oral Azacitidine plus Best Supportive care versus Placebo and Best Supportive care in subjects with red blood cell (RBC) transfusion-dependent anemia and thrombocytopenia due to International Prognostic Scoring System (IPSS) lower risk myelodysplastic syndromes (MDS).
Ages: 18 years and older
Dates: 08/10/2017 - 10/01/2021
Last Updated: 08/11/2017
Study HIC#: 1604017647